FDA Targets Medical Device Companies

by Polsinelli
Contact

FDA Developing New Risk and Benefit Perception Scale

Since 2008, the U.S. Food and Drug Administration has increased its presence and tightened its control over medical device companies, and this trend is expected to continue through at least 2016.

Earlier this month, FDA released its 2012 medical device enforcement data, which evidenced:

  • A significant increase in the number of inspections.
  • A significant increase in the number of quality system warning letters issued.
  • A significant increase in foreign facility increase and disproportionate increase in quality system warning letters issued to foreign firms.

I. Quality System Inspections and Warning Letters on the Rise

In 2008, FDA conducted 2271 facility inspections. By 2012, that number had risen to 2748 – a 37 percent increase overall.

During those 2748 inspections of 2012, FDA made 4243 observations, the most common of which were:

  • Failures in corrective and preventative actions (CAPA) (i.e., regulations aimed at addressing complaints and nonconforming products), which was observed in 30% of the observations (1258 of 4243 observations) and
  • Inadequate production and process controls (P&PC), which was also observed in 30% of the observations (1303 of the 4243 observations).

While overall document control and retention observations were only found in 11% of all observations, the number of observations related to the maintenance of a device history record (a record that includes dates of manufacture, quantity of manufacture, quantity released, acceptance record, label, and control labels) increased significantly between 2011 and 2012 (173 observations to 190).

The increased number of inspections led to an unsurprising increase in the number of warning letters issued:

  • 2012: 164 warning letters
  • 2011: 122 warning letters
  • 2010: 89 warning letters
  • 2009: 77 warning letters

The most frequent warning letter violations centered on CAPA violations (32% of all warning letters) and P&PC violations (30% of all violations). Similarly, there was a noticeable increase in warning letters related to design history document retention issues (51 warning letters). Also noted by the FDA was an increase warning letters related to P&PC-related process validation violations (49 warning letters).

II. Foreign Facilities Are Taken to Task

While overall numbers showed a rise of routine quality system surveillance inspections of 37 percent, foreign facilities alone experienced a 93 percent increase, and a disproportionate amount of violations. That is, while foreign firms accounted for 300 of the 2748 inspections (10%), they accounted for 66 of the 164 warning letters (40%).

FDA attributes this fact to not only increased focus, but improved site selection, with enforcement spread equally between Europe and Asia:

  • Approximately one third of the warning letters issued to foreign facilities were directed at Chinese firms (20 of 66).
  • Another third were directed at European facilities (Germany-9; Italy-6; UK-6; and Denmark-3).
  • The remaining warning letters were issued to Japanese (3), Taiwanese (3), and Canadian (2) establishments.

 

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Polsinelli | Attorney Advertising

Written by:

Polsinelli
Contact
more
less

Polsinelli on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.